Loading...
EVE Health Group Limited
EVE.AX•ASX
Consumer Defensive
Packaged Foods
A$0.04
A$0.00(0.00%)
EVE Health Group Limited (EVE.AX) Financial Performance & Income Statement Overview
Review EVE Health Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-8.45%
↓ 8.45%
Operating Income Growth
32.37%
↑ 32.37%
Net Income Growth
52.99%
↑ 52.99%
Operating Cash Flow Growth
32.87%
↑ 32.87%
Operating Margin
-61.53%
↓ 61.53%
Gross Margin
29.007%
↑ 29.007%
Net Profit Margin
-87.74%
↓ 87.74%
ROE
-214.33%
↓ 214.33%
ROIC
-295.69%
↓ 295.69%
EVE Health Group Limited (EVE.AX) Income Statement & Financial Overview
Review EVE Health Group Limited's (EVE.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $1.006M | $998023.00 | $1.14M | $948209.00 |
| Cost of Revenue | $525183.00 | $897796.00 | $1.03M | $1.18M |
| Gross Profit | $481181.00 | $100227.00 | $100978.00 | -$231990.00 |
| Gross Profit Ratio | $0.48 | $0.10 | $0.09 | -$0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $999234.00 | $815502.00 | $929233.00 | $847370.00 |
| Operating Expenses | $999234.00 | $815502.00 | $1.15M | $822770.00 |
| Total Costs & Expenses | $1.52M | $1.71M | $1.96M | $2.003M |
| Interest Income | $0.00 | $33312.00 | $0.00 | $0.00 |
| Interest Expense | $26958.00 | $0.00 | $34697.00 | $19070.00 |
| Depreciation & Amortization | $179.00 | $834.00 | $6207.00 | $30424.00 |
| EBITDA | -$652000.00 | -$684000.00 | -$823000.00 | -$899428.00 |
| EBITDA Ratio | -$0.65 | -$0.69 | -$0.72 | -$1.08 |
| Operating Income | -$518000.00 | -$715000.00 | -$828000.00 | -$1.05M |
| Operating Income Ratio | -$0.51 | -$0.72 | -$0.73 | -$1.11 |
| Other Income/Expenses (Net) | -$161000.00 | $30462.00 | -$175000.00 | $105842.00 |
| Income Before Tax | -$679000.00 | -$685000.00 | -$864000.00 | -$948918.00 |
| Income Before Tax Ratio | -$0.67 | -$0.69 | -$0.76 | -$1.001 |
| Income Tax Expense | $0.00 | $0.00 | $85346.00 | $1.69M |
| Net Income | -$807000.00 | -$952000.00 | -$949000.00 | -$2.64M |
| Net Income Ratio | -$0.80 | -$0.95 | -$0.84 | -$2.79 |
| EPS | -$0.00 | -$0.00 | -$0.00 | -$0.001 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.001 |
| Weighted Avg Shares Outstanding | $6.40B | $5.27B | $5.27B | $5.27B |
| Weighted Avg Shares Outstanding (Diluted) | $5.38B | $5.27B | $5.27B | $5.27B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan